BCM Advisors’s Novartis NVS Stock Holding History

BCM Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-446	Closed	-$29K	–	70
2016 Q4	$29K	Buy	+446	New	+$28.9K	0.02%	54

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BCM Advisors's NVS Position: Q1 2017 in Review

BCM Advisors sold out of Novartis (NVS) in Q1 2017, closing a stake of 446 shares — an estimated $29K sold.

BCM Advisors first reported a position in NVS in Q4 2016 and held it in 1 quarter. The position peaked at $29K in Q4 2016. 909 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

BCM Advisors reported no remaining Novartis position as of Q1 2017 after selling out during the quarter.
BCM Advisors sold 446 Novartis shares in Q1 2017, an estimated $29K.
BCM Advisors first reported a position in Novartis in Q4 2016 and held it in 1 quarter.
BCM Advisors's Novartis position peaked at $29K in Q4 2016.
909 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on BCM Advisors's 13F filing for Q1 2017, filed 12 May 2017.